rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2001-1-4
|
pubmed:abstractText |
Recently, the combination treatment of recombinant alpha-interferon plus ribavirin has been proposed for chronic hepatitis C patients unresponsive to previous therapy with recombinant alpha-interferon alone.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1590-8658
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
703-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11142581-Alanine Transaminase,
pubmed-meshheading:11142581-Antiviral Agents,
pubmed-meshheading:11142581-Drug Administration Schedule,
pubmed-meshheading:11142581-Drug Therapy, Combination,
pubmed-meshheading:11142581-Female,
pubmed-meshheading:11142581-Hepatitis C, Chronic,
pubmed-meshheading:11142581-Humans,
pubmed-meshheading:11142581-Interferon Type I,
pubmed-meshheading:11142581-Male,
pubmed-meshheading:11142581-Middle Aged,
pubmed-meshheading:11142581-Recombinant Proteins,
pubmed-meshheading:11142581-Ribavirin,
pubmed-meshheading:11142581-Treatment Failure,
pubmed-meshheading:11142581-Viral Load
|
pubmed:year |
2000
|
pubmed:articleTitle |
High-dose interferon plus ribavirin in chronic hepatitis C not responding to recombinant alpha-interferon.
|
pubmed:affiliation |
Gastroenterology Unit, Azienda Ospedaliera Pisana, Italy. bresci@plus.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|